Cytotoxic aldehydes as possible markers for childhood cancer

Free Radical Biology and Medicine

Volumn 23, Issue 6, 1997, Pages 870-878

  Yazdanpanah, Mehrdad ^a   Luo, Xiaoping ^a   Lau, Robert ^b   Greenberg, Mark ^b   Fisher, Lawrence J ^a   Lehotay, Denis C ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aldehydes; Cancer; Carnitine; Doxorubicin; Free radicals; Lipid peroxidation; Mass spectrometry; Oxidative stress

Indexed keywords

4 DECENAL; ACYLCARNITINE; ALDEHYDE; CARNITINE; DAUNORUBICIN; DOXORUBICIN; HEPTYL ALDEHYDE; HEXANAL; MALONALDEHYDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LIPID PEROXIDATION; PLASMA; PRIORITY JOURNAL; URINE;

ADOLESCENT; ALDEHYDES; BONE NEOPLASMS; BURKITT LYMPHOMA; CARNITINE; CHILD; CHILD, PRESCHOOL; DOXORUBICIN; HUMANS; INFANT; LEUKEMIA, MYELOCYTIC, ACUTE; LIPID PEROXIDATION; LYMPHOMA, LARGE-CELL; MALONDIALDEHYDE; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030803149     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00070-1     Document Type: Article

References (32)

1. Mlakar A., Spiteller G. Reinvestigation of lipid peroxidation of linolenic acid. Biochimi. Biophysi. Acta. 1214:1994;209-220.
2. Bruenner B. A., Jones A. D., German J. B. Direct characterization of protein adducts of the lipid peroxidation product 4-Hydroxy-2-nonenal using electrospray mass spectrometry. Chem. Res. Toxicol. 8:((4)):1995;552-559.
3. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence? Lancet. 344:1994;721-724.
4. Szatrowski T. P., Nathan C. F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51:1991;794-798.
5. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Hypothesis; Persistent oxidative stress in cancer. FEBS Let. 358:1995;1-3.
6. Okamato K., Toyokuni S., Uchida K., Ogawa O., Takenawa J., Kakehi Y., Kinoshita H., Hattori-Nakakuti Y., Hiai H., Yoshida O. Formation of 8-hydroxy-2 -deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int. J. Cancer. 58:((6)):1994;825-829.
7. Mitsui A., Hirakawa T., Yodoi J. Reactive oxygen-reducing and protein-refolding activities of adult T-cell leukemia-derived factor/human thioredoxin. Biochem. Biophys. Res. Commun. 186:((3)):1992;1220-1226.
8. Perry R.R., Mezetta J., Levin M., Barranco S. C. Glutathione levels and variability in breast tumors and normal tissues. Cancer. 72:((3)):1993;783-787.
9. Hatcher E. L., Chen Y., King Y. J. Cadmium resistance in A549 cells correlates with elevated glutathione content but not antioxidant enzymatic activities. Free Radic. Biol. Med. 19:((6)):1995;805-812.
10. Baronzio G., Freitas I., Griffini P., Bertone V., Pacini F., Mascaro G., Razzini E., Gramaglia A. Omega-3 fatty acids can improve radioresponse modifying tumor interstitial pressure, blood rheology and membrane peroxidability. Anticancer Res. 14:1994;1145-1154.
11. Booser D. J., Hortobagyi G. N. Anthracycline antibiotics in cancer therapy. Drugs. 47:((2)):1994;223-258.
12. Lown J. W. Anthracycline and anthraquinone anticancer agents: Current status and recent developments. Pharmac. Ther. 60:1993;185-214.
13. Ali M. K., Ewer M. S., Gibbs H. R., Swafford J., Graff K. L. Late Doxorubicine-associated cardiotoxicity in children. Cancer. 74:((1)):1994;182-188.
14. Goormaghtigh E., Huart P., Praet M., Brasseur R., Ruysschaert J. M. Structure of the Doxorubicin-Cardiolipin complex role in mitochondrial toxicity. Biophys. Chem. 35:1990;247-257.
15. Shug A. L. Protection from Doxorubicin-induced cardiomyopathy in rats. Z. Kardiol. 76:((Suppl 5)):1987;46-52.
16. De Leonardis V., De Scalzi M., Neri B., Bartalucci S., Cinelli P. Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens. Int. J. Clin. Pharmacol. Res. 7:1987;307-411.
17. McFalls E. O., Paulson D. J., Gilbert E. F., Shug A. L. Carnitine protection against Doxorubicin-induced cardiomyopathy in rats. Life Sci. 38:1986;497-505.
18. Luo X. P., Yazdanpanah M., Bhooi N., Lehotay D. C. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal. Biochem. 228:1995;294-298.
19. Maeda J., Dudrick S. J. Rapid spectrophotometric determination of plasma carnitine concentrations. J. Parenteral Enteral Nutr. 14:1990;527-532.
20. Roe C. R., Millington D. S., Maltby D.A. Borum P.R. Clinical aspects of human carnitine deficiency. 1985;97-107 Pergamon Press, New York.
21. Ames, B. N; Gold, L.S.; Willett, W. C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA 92:5258-5256; 1995.
22. Malins D. C, Polissar N. L, Gunselman S. J. Progression of human breast cancer to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc. Natl. Acad. Sci. USA. 93:1996;2557-2563.
23. Toyokuni S., Luo X. P., Tanaka T., Uchida K., Hiai H., Lehotay D. C. Induction of a wide range of C2-C12 aldehydes and C7-C12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitriloacetate. Free Rad. Biol. Med. 22:1997;1019-1027.
24. Sherwood L. Human physiology from cell to systems. 2nd Ed. 1993;West Publishing Company, Minneapolis/St. Paul; New York.
25. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Rad. Biol. Med. 8:((6)):1990;583-599.
26. Sato K., Ito K., Kohara H., Yamaguchi Y., Adechi K., Endo H. Negative regulation of catalase gene expression in hepatoma cell. Mol. Cell. Biol. 12:1992;2525-2533.
27. Volm M., Sauerbrey A., Zyntl F. Prognostic significance of protein kinase C in newly diagnosed childhood acute lymphoblastic leukemia. Int. J. Oncology. 4:1994;363-368.
28. Burns C. P., Spector A. A. Membrane fatty acid modification in tumor cells: A potential therapeutic adjunct. Lipids. 22:1987;178-184.
29. Luo X. P., Evrovsky Y., Cole D., Trines J., Benson L. N., Lehotay D. C. Doxorubicin-induced acute changes in cytotoxic aldehydes, antioxidant status and cardiac function in the rat. Biochim Biophys Acta. 1360:1997;45-52.
30. Bagchi M., Hassoun E. A., Kelly J., Stohs S. J. Doxorubicin-induced hepatic and myocardial lipid peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites in rats. Toxicology. 95:1995;1-9.
31. Yoshida M., Yanagisawa R., Ishida Y., Kishi H. Influence of cytotoxic chemotherapy on superoxide production by neutrophils in cancer patients. Kansenshogaku Zasshi-J. Japanese Association for Infectious. Diseases. 67:((1)):1993;30-35.
32. Bowen P. E., Mobarhan S. Evidence from cancer intervention and biomarker studies and the development of biochemical markers. Am. J. Clin. Nutr. 62:((suppl)):1995;1403S-1409S.